FR2391202A1 - Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines - Google Patents

Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines

Info

Publication number
FR2391202A1
FR2391202A1 FR7814417A FR7814417A FR2391202A1 FR 2391202 A1 FR2391202 A1 FR 2391202A1 FR 7814417 A FR7814417 A FR 7814417A FR 7814417 A FR7814417 A FR 7814417A FR 2391202 A1 FR2391202 A1 FR 2391202A1
Authority
FR
France
Prior art keywords
triazines
substituted
pharmacologically active
products containing
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814417A
Other languages
English (en)
Other versions
FR2391202B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diamond Shamrock Corp
Original Assignee
Diamond Shamrock Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/897,803 external-priority patent/US4157392A/en
Application filed by Diamond Shamrock Corp filed Critical Diamond Shamrock Corp
Publication of FR2391202A1 publication Critical patent/FR2391202A1/fr
Application granted granted Critical
Publication of FR2391202B1 publication Critical patent/FR2391202B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne l'industrie pharmaceutique. On prépare des nouvelles triazines substituées I possédant des propriétés pharmacologiques telles que des effets anti-inflammatoires, analgésiques, anti-pyrétiques, hypotensifs et agissant sur le système nerveux central. Application comme médicaments.
FR7814417A 1977-05-17 1978-05-16 Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines Granted FR2391202A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79767677A 1977-05-17 1977-05-17
US05/897,803 US4157392A (en) 1977-05-17 1978-04-19 Pharmacologically active substituted 1,2,4-triazines

Publications (2)

Publication Number Publication Date
FR2391202A1 true FR2391202A1 (fr) 1978-12-15
FR2391202B1 FR2391202B1 (fr) 1982-04-02

Family

ID=27121911

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814417A Granted FR2391202A1 (fr) 1977-05-17 1978-05-16 Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines

Country Status (8)

Country Link
JP (1) JPS5416491A (fr)
CA (1) CA1128507A (fr)
CH (1) CH633541A5 (fr)
DE (1) DE2821381A1 (fr)
FR (1) FR2391202A1 (fr)
GB (3) GB1604085A (fr)
IL (1) IL54728A (fr)
IT (1) IT1105463B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EP0077983A1 (fr) * 1981-10-22 1983-05-04 Fujisawa Pharmaceutical Co., Ltd. Dérivés de triazine, leur procédé de préparation et les compositions pharmaceutiques les contenant
EP0088593A2 (fr) * 1982-03-05 1983-09-14 Eli Lilly And Company Dérivés de 1,2,4-triazine et de pyrazine
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
TWI316055B (fr) * 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
CN102822150B (zh) 2010-02-05 2014-12-03 赫普泰雅治疗有限公司 1,2,4-三嗪-4-胺衍生物
FR2974099B1 (fr) * 2011-04-14 2013-04-19 Michelin Soc Tech Composition de caoutchouc comprenant un derive de la 1,2,4-triazine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2343478A1 (fr) * 1976-03-10 1977-10-07 Lilly Co Eli Nouvelles 5,6-diaryl-1,2,4-triazines et leur utilisation comme agents anti-inflammatoires locaux
FR2368278A1 (fr) * 1976-10-25 1978-05-19 Fabre Sa Pierre Nouveaux medicaments antalgiques contenant des triazines 1-2-4

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2343478A1 (fr) * 1976-03-10 1977-10-07 Lilly Co Eli Nouvelles 5,6-diaryl-1,2,4-triazines et leur utilisation comme agents anti-inflammatoires locaux
FR2368278A1 (fr) * 1976-10-25 1978-05-19 Fabre Sa Pierre Nouveaux medicaments antalgiques contenant des triazines 1-2-4

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EP0077983A1 (fr) * 1981-10-22 1983-05-04 Fujisawa Pharmaceutical Co., Ltd. Dérivés de triazine, leur procédé de préparation et les compositions pharmaceutiques les contenant
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
EP0088593A2 (fr) * 1982-03-05 1983-09-14 Eli Lilly And Company Dérivés de 1,2,4-triazine et de pyrazine
EP0088593A3 (en) * 1982-03-05 1984-05-23 Eli Lilly And Company 1,2,4-triazine and pyrazine derivatives
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
IL54728A0 (en) 1978-07-31
GB1604085A (en) 1981-12-02
IL54728A (en) 1983-06-15
GB1604084A (en) 1981-12-02
DE2821381A1 (de) 1978-11-30
CH633541A5 (en) 1982-12-15
IT1105463B (it) 1985-11-04
FR2391202B1 (fr) 1982-04-02
GB1604083A (en) 1981-12-02
IT7849404A0 (it) 1978-05-16
CA1128507A (fr) 1982-07-27
JPS5416491A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
DK0608322T3 (da) Forbedret hudpenetreringssystem til forbedret topisk frembringelse af lægemidler
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
MY102392A (en) Pharmaceutical products providing enhanced analgesia.
FR2694290B1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
JO1502B1 (en) New pharmacy vehicles
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
OA06719A (fr) Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
ES431675A1 (es) Un procedimiento para preparar compuestos de hexahidro-di- benzo(b,d) piran-9-ona.
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
FR2352791A1 (fr) P. acylaminobenzamides, procede pour leur preparation et medicaments contenant ces benzamides
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
FR2701708B1 (fr) Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2615512B1 (fr) Composes de benzamides substitues pharmacologiquement actifs, compositions pharmaceutiques contenant ces composes, et leur procede de preparation
FR2391202A1 (fr) Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ES2088956T3 (es) Estructura de tableta multifraccionable.
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
BE867085A (fr) Triazines-1,2,4 substituees actives pharmacologiquement et medicaments contenant ces triazines
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
IT8125243A0 (it) Composti ad attivita'analgesica e antiinfiammatoria, processo per la loro preparazione e relative composizioni farmaceutiche.
FR2575159B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation, leur utilisation comme medicaments et les compositions pharmaceutiques les contenant
FR2422647A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse